Evidence in Support of Potential Applications of Lipid Peroxidation Products in Cancer Treatment

Cancer cells generate reactive oxygen species (ROS) resulting frommitochondrial dysfunction, stimulation of oncogenes, abnormal metabolism, and aggravated inflammatory activities. Available evidence also suggests that cancer cells depend on intrinsic ROS level for proliferation and survival. Both...

Full description

Bibliographic Details
Main Authors: Erejuwa, Omotayo O., Sulaiman, Siti A., Wahab, Mohd S. Ab
Format: Article
Language:English
Published: Hindawi Publishing Corporation 2013
Subjects:
Online Access:http://eprints.usm.my/39046/1/Evidence_in_Support_of_Potential_Applications_of_Lipid_Peroxidation_Products_in_Cancer_Treatment.pdf
_version_ 1825833975001645056
author Erejuwa, Omotayo O.
Sulaiman, Siti A.
Wahab, Mohd S. Ab
author_facet Erejuwa, Omotayo O.
Sulaiman, Siti A.
Wahab, Mohd S. Ab
author_sort Erejuwa, Omotayo O.
collection USM
description Cancer cells generate reactive oxygen species (ROS) resulting frommitochondrial dysfunction, stimulation of oncogenes, abnormal metabolism, and aggravated inflammatory activities. Available evidence also suggests that cancer cells depend on intrinsic ROS level for proliferation and survival. Both physiological and pathophysiological roles have been ascribed to ROS which cause lipid peroxidation. In spite of their injurious effects, the ROS and the resulting lipid peroxidation products could be beneficial in cancer treatment. This reviewpresents research findings suggesting that ROS and the resulting lipid peroxidation products could be utilized to inhibit cancer growth or induce cancer cell death. It also underscores the potential of lipid peroxidation products to potentiate the antitumor effect of other anticancer agents.The review also highlights evidence demonstrating other potential applications of lipid peroxidation products in cancer treatment. These include the prospect of lipid peroxidation products as a diagnostic tool to predict the chances of cancer recurrence, to monitor treatment progress or how well cancer patients respond to therapy. Further and detailed research is required on how best to successfully, effectively, and selectively target cancer cells in humans using lipid peroxidation products.This may prove to be an important strategy to complement current treatment regimens for cancer patients.
first_indexed 2024-03-06T15:15:47Z
format Article
id usm.eprints-39046
institution Universiti Sains Malaysia
language English
last_indexed 2024-03-06T15:15:47Z
publishDate 2013
publisher Hindawi Publishing Corporation
record_format dspace
spelling usm.eprints-390462018-02-20T04:30:15Z http://eprints.usm.my/39046/ Evidence in Support of Potential Applications of Lipid Peroxidation Products in Cancer Treatment Erejuwa, Omotayo O. Sulaiman, Siti A. Wahab, Mohd S. Ab RM Therapeutics. Pharmacology Cancer cells generate reactive oxygen species (ROS) resulting frommitochondrial dysfunction, stimulation of oncogenes, abnormal metabolism, and aggravated inflammatory activities. Available evidence also suggests that cancer cells depend on intrinsic ROS level for proliferation and survival. Both physiological and pathophysiological roles have been ascribed to ROS which cause lipid peroxidation. In spite of their injurious effects, the ROS and the resulting lipid peroxidation products could be beneficial in cancer treatment. This reviewpresents research findings suggesting that ROS and the resulting lipid peroxidation products could be utilized to inhibit cancer growth or induce cancer cell death. It also underscores the potential of lipid peroxidation products to potentiate the antitumor effect of other anticancer agents.The review also highlights evidence demonstrating other potential applications of lipid peroxidation products in cancer treatment. These include the prospect of lipid peroxidation products as a diagnostic tool to predict the chances of cancer recurrence, to monitor treatment progress or how well cancer patients respond to therapy. Further and detailed research is required on how best to successfully, effectively, and selectively target cancer cells in humans using lipid peroxidation products.This may prove to be an important strategy to complement current treatment regimens for cancer patients. Hindawi Publishing Corporation 2013 Article PeerReviewed application/pdf en http://eprints.usm.my/39046/1/Evidence_in_Support_of_Potential_Applications_of_Lipid_Peroxidation_Products_in_Cancer_Treatment.pdf Erejuwa, Omotayo O. and Sulaiman, Siti A. and Wahab, Mohd S. Ab (2013) Evidence in Support of Potential Applications of Lipid Peroxidation Products in Cancer Treatment. Oxidative Medicine and Cellular Longevity, 2013 (931251). pp. 1-8. ISSN 1942-0900 http://dx.doi.org/10.1155/2013/931251
spellingShingle RM Therapeutics. Pharmacology
Erejuwa, Omotayo O.
Sulaiman, Siti A.
Wahab, Mohd S. Ab
Evidence in Support of Potential Applications of Lipid Peroxidation Products in Cancer Treatment
title Evidence in Support of Potential Applications of Lipid Peroxidation Products in Cancer Treatment
title_full Evidence in Support of Potential Applications of Lipid Peroxidation Products in Cancer Treatment
title_fullStr Evidence in Support of Potential Applications of Lipid Peroxidation Products in Cancer Treatment
title_full_unstemmed Evidence in Support of Potential Applications of Lipid Peroxidation Products in Cancer Treatment
title_short Evidence in Support of Potential Applications of Lipid Peroxidation Products in Cancer Treatment
title_sort evidence in support of potential applications of lipid peroxidation products in cancer treatment
topic RM Therapeutics. Pharmacology
url http://eprints.usm.my/39046/1/Evidence_in_Support_of_Potential_Applications_of_Lipid_Peroxidation_Products_in_Cancer_Treatment.pdf
work_keys_str_mv AT erejuwaomotayoo evidenceinsupportofpotentialapplicationsoflipidperoxidationproductsincancertreatment
AT sulaimansitia evidenceinsupportofpotentialapplicationsoflipidperoxidationproductsincancertreatment
AT wahabmohdsab evidenceinsupportofpotentialapplicationsoflipidperoxidationproductsincancertreatment